Gilead Sciences: all 734 studies

Page 7 of 8. Open to participants first (33), then studies with results posted, then the rest; newest registration first within each.

• A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis CCompletedNCT01225380Phase 2
• A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis CCompletedNCT01193478Phase 1
• Ranolazine in Diastolic Heart FailureCompletedNCT01163734Phase 2
• A Study of hLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple MyelomaTerminatedNCT01101594Phase 1/2
• Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHLWithdrawnNCT01101581Phase 1/2
• Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus InfectionCompletedNCT01072695Phase 2
• Study to Investigate Effects of CAL-263 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental ChamberCompletedNCT01066611Phase 1
• Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa InfectionCompletedNCT01055847Phase 2
• Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 DiabetesCompletedNCT01035879Phase 2
• A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF)WithdrawnNCT01025713Phase 1
• A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial of GS-9411 in Healthy VolunteersCompletedNCT00999531Phase 1
• Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic FibrosisApproved for marketingNCT00989807
• A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male VolunteersCompletedNCT00951522Phase 1
• Stress Echocardiography Study With RegadenosonTerminatedNCT00907764Phase 2
• Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus InfectionTerminatedNCT00874796Phase 2
• Study to Investigate Effects of CAL-101 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental ChamberCompletedNCT00836914Phase 1
• Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)TerminatedNCT00832507Phase 2
• Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on MetforminTerminatedNCT00814372Phase 2
• Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male VolunteersCompletedNCT00800579Phase 1
• Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung InfectionCompletedNCT00794586Phase 2
• ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation TrialCompletedNCT00772902Phase 4
• Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV InfectionCompletedNCT00743795Phase 2
• Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)CompletedNCT00740610Phase 2
• Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCVCompletedNCT00725803Phase 2
• Safety Study of Tecadenoson to Treat Atrial FibrillationCompletedNCT00713401Phase 2
• Dose Escalation Study of CAL-101 in Select Relapsed or Refractory Hematologic MalignanciesCompletedNCT00710528Phase 1
• Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High CholesterolCompletedNCT00701883Phase 2
• CRITIC - Treatment of Candidemia and Invasive CandidiasisCompletedNCT00670657Phase 4
• Efficacy Study of CYT997 in Multiple MyelomaTerminatedNCT00664378Phase 2
• Efficacy Study of CYT997 in Combination With Carboplatin in GlioblastomaTerminatedNCT00650949Phase 1/2
• Metabolic Impact Assessment of Tenofovir Disoproxil Fumarate on Non-HIV-1 Infected Healthy Adult Male VolunteersCompletedNCT00648817Phase 4
• Study to Evaluate Changes in Limb Fat When Switching From a Thymidine AnalogueCompletedNCT00647946Phase 2
• CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation StudyCompletedNCT00645736
• Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBVCompletedNCT00645294Phase 1/2
• PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant PatientsCompletedNCT00644761Phase 2
• Tenofovir DF + Efavirenz (TDF+EFV) Versus Tenofovir DF + Efavirenz + Lamivudine (TDF+EFV+3TC) Maintenance Regimen in Virologically Controlled Patients: COOL TrialCompletedNCT00643968Phase 4
• An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric SubjectsCompletedNCT00642291Phase 2
• ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation TrialCompletedNCT00615810Phase 4
• ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to AtriplaCompletedNCT00615745Phase 4
• Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic CancerCompletedNCT00603863Phase 1/2
• Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLLCompletedNCT00603668Phase 1/2
• Safety and Efficacy Study of 90Y-hPAM4 at Different DosesCompletedNCT00597129Phase 1/2
• Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's LymphomaCompletedNCT00596804Phase 1/2
• Study of Veltuzumab (hA20) at Different Doses in Patients With ITPTerminatedNCT00547066Phase 1/2
• Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLLCompletedNCT00546793Phase 1/2
• Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital WartsCompletedNCT00499967Phase 1
• Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway InfectionApproved for marketingNCT00499720
• A Trial of GS-9219 in Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM)TerminatedNCT00499239Phase 1/2
• Fanconi Syndrome Due to ARVs in HIV-Infected PersonsCompletedNCT00499187
• Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B VirusTerminatedNCT00496158Phase 3
• Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B VirusTerminatedNCT00496002Phase 3
• Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.CompletedNCT00423748Phase 3
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.CompletedNCT00423202Phase 3
• Safety and Tolerability Study of MBX-2044 in Patients With Type 2 DiabetesCompletedNCT00422487Phase 2
• Phase I/II Study of hLL1 in Multiple MyelomaCompletedNCT00421525Phase 1/2
• Safety Study of NHL With 90Y-hLL2 IgGCompletedNCT00421395Phase 1/2
• Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to AntibioticsTerminatedNCT00421187Phase 4
• DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant HypertensionCompletedNCT00389779Phase 3
• DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant HypertensionTerminatedNCT00389675Phase 3
• ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic LeukemiaTerminatedNCT00386997Phase 4
• Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and RibavirinCompletedNCT00382798Phase 1/2
• Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected PatientsCompletedNCT00365612Phase 4
• A Clinical Study to Evaluate the Effects of Darusentan on Safety and Efficacy in Subjects With Resistant Systolic Hypertension Receiving Combination Therapy With Three or More Blood Pressure Lowering DrugsCompletedNCT00364026Phase 2
• GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With ResistanceCompletedNCT00362687Phase 4
• PROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute LeukaemiaCompletedNCT00362544Phase 4
• Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on InsulinCompletedNCT00353587Phase 2/3
• DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant HypertensionTerminatedNCT00353574Phase 3
• COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive AspergillosisCompletedNCT00334412Phase 4
• DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant HypertensionCompletedNCT00330369Phase 3
• PROPHESSOR: AmBisome in Antifungal Primary Prophylaxis Treatment of High Risk Patients Undergoing Allogeneic Stem Cell TransplantationCompletedNCT00326157Phase 2
• Safety Study of Once a Day ART and Opiate Substitute.CompletedNCT00324688Phase 4
• SONETT: Switch Study to Once Daily HIV Treatment Regimen With TruvadaCompletedNCT00323687Phase 4
• SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV InfectionCompletedNCT00323544Phase 3
• Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.CompletedNCT00298350Phase 2
• Study of hA20 (Humanized Anti-CD20) in Patients With CD20+ Non-Hodgkin's LymphomaCompletedNCT00285428Phase 1/2
• Phase II Comparator Study of Substitution of Tenofovir or Abacavir Receiving Thymidine Analogue as Part of HAART.CompletedNCT00270556Phase 2
• Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.CompletedNCT00263614
• Combination of Efavirenz and Truvada - COMET StudyCompletedNCT00224458Phase 4
• Boosted Atazanavir and Truvada Given Once-Daily - BATON StudyCompletedNCT00224445Phase 4
• ADVANCE MPI 2: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)CompletedNCT00208312Phase 3
• ADVANCE MPI 1: Study of Regadenoson Versus Adenoscan® in Patients Undergoing Myocardial Perfusion Imaging (MPI)CompletedNCT00208299Phase 3
• Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.CompletedNCT00158821Phase 3
• Study Safety/Efficacy of AmBisome Loading Dose Regimen Versus Standard AmBisome Regimen for Initial TreatmentCompletedNCT00158730Phase 3
• Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.CompletedNCT00158717
• Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.TerminatedNCT00158704Not applicable
• Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV SubjectsCompletedNCT00121979Phase 2
• Study of Epratuzumab (hLL2) in Patients With Waldenstrom's MacroglobulinemiaTerminatedNCT00113802Phase 2
• Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 PatientsCompletedNCT00106379Phase 4
• Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary SyndromesCompletedNCT00099788Phase 3
• ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)CompletedNCT00091598Phase 3
• Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With AmlodipineCompletedNCT00091429Phase 3
• Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart FailureTerminatedNCT00077948Phase 3
• Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis BCompletedNCT00071201Phase 3
• Treatment of Non-Hodgkin's Lymphoma With 90Y-hLL2 IgGCompletedNCT00061425Phase 1/2
• Study of 90Y-hLL2 to Treat Non-Hodgkin's LymphomaTerminatedNCT00054834Phase 1
• ESSENTIAL-"The Studies of Oral Enoximone Therapy in Advanced Heart Failure"TerminatedNCT00051285Phase 3
• Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial HypertensionCompletedNCT00046319Phase 2
• An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment OptionsApproved for marketingNCT00042393
• Safety Study of 90Y-hMN14 to Treat Colorectal Cancer Patients With Limited Residual Disease After SurgeryTerminatedNCT00041691Phase 1
• Safety Study of hMN14 to Treat Either Colorectal or Breast CancerCompletedNCT00041652Phase 1/2

← Gilead Sciences overview and focus areas